Heart failure is increasing in prevalence in many countries with aging populations.
Fortunately, remarkable scientific advances have been made in the past few years that have …

Abstract Background In the TRILUMINATE Pivotal (Trial to Evaluate Cardiovascular
Outcomes in Patients Treated with the Tricuspid Valve Repair System Pivotal), tricuspid …

BACKGROUND: Compared with men, women with hypertrophic cardiomyopathy (HCM)
have a higher incidence of heart failure and worse outcomes. We investigated baseline …

Background In nonobstructive hypertrophic cardiomyopathy (nHCM), there are no approved
medical therapies. Impaired myocardial energetics is a potential cause of symptoms and …

Background Studies on the predictive ability of disease‐specific health quality of life (QoL) in
patients with heart failure (HF) have produced conflicting results. To address these gaps in …

Background Heart failure is a common complication after myocardial infarction (MI) and is
associated with increased mortality. Whether remote heart failure symptoms assessment …

BACKGROUND: The impact of routine clinic use of patient-reported outcome (PRO)
measures on clinical outcomes in patients with heart failure (HF) has not been well …

Introduction The current guidelines strongly recommend early initiation of multiple classes of
cardioprotective drugs for patients with heart failure with reduced ejection fraction to improve …

Background Heart failure (HF) patients often experience poor health-related quality-of-life
(HR-QoL). The Kansas City Cardiomyopathy Questionnaire (KCCQ) is frequently used for …

Background: Heart failure (HF) is a common disease caused by inability of the heart to pump
for supporting the circulation and the functional abnormalities of the heart. The present study …